{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:02Z","timestamp":1767134762922,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":56,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003420.pub3","type":"reference-entry","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T10:35:41Z","timestamp":1114166141000},"source":"Crossref","is-referenced-by-count":12,"title":["Antithyroid drug regimen for treating Graves' hyperthyroidism"],"prefix":"10.1002","author":[{"given":"Prakash","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Avenell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S","family":"Bevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"key":"10.1002\/14651858.CD003420.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1210\/jcem-70-3-675","article-title":"Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration","volume":"70","author":"Allannic","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"14","key":"10.1002\/14651858.CD003420.pub3-BIB2|cit2","first-page":"649","article-title":"Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy","volume":"20","author":"Allannic","year":"1991","journal-title":"Presse Medicale"},{"issue":"4","key":"10.1002\/14651858.CD003420.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2265.1998.00554.x","article-title":"Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs","volume":"49","author":"Benker","year":"1998","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD003420.pub3-BIB4|cit4","first-page":"1516","volume":"76","author":"Reinwein","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD003420.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2265.1992.tb02269.x","volume":"36","author":"Cho","year":"1992","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB7|cit6","unstructured":"Edmonds CJ Personal Communication"},{"issue":"2","key":"10.1002\/14651858.CD003420.pub3-BIB6|cit7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1530\/eje.0.1310120","article-title":"Treatment of Graves' disease by carbimazole: high dose with thyroxine compared to titration dose","volume":"131","author":"Edmonds","year":"1994","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/BF03348811","volume":"15","author":"Garcia-Mayor","year":"1992","journal-title":"Journal of Endocrinology and Investigation"},{"issue":"4","key":"10.1002\/14651858.CD003420.pub3-BIB10|cit9","first-page":"A296","article-title":"Clinical epidemiology of Basedow's disease in Belgium","volume":"21","author":"Glinoer","year":"2000","journal-title":"Revue Medicale de Bruxelles"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB9|cit10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1530\/eje.0.1440475","volume":"144","author":"Glinoer","year":"2001","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB11|cit11","first-page":"11","article-title":"Recurrence of Graves-Basedow disease: the influence of treatment schedule","volume":"104","author":"Goni Iriarte","year":"1995","journal-title":"Medicina Clinica"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-2265.1998.00446.x","volume":"48","author":"Grebe","year":"1998","journal-title":"Clinical Endocrinology"},{"issue":"14","key":"10.1002\/14651858.CD003420.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199104043241403","volume":"324","author":"Hashizume","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003420.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/105072502321085225","article-title":"Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine","volume":"12","author":"Hoermann","year":"2002","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD003420.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00108-003-0876-x","volume":"44","author":"Quadbeck","year":"2003","journal-title":"Internist"},{"issue":"2","key":"10.1002\/14651858.CD003420.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2796.1995.tb00914.x","article-title":"Short-term treatment of Graves' disease with methimazole in high versus low doses","volume":"238","author":"Jorde","year":"1995","journal-title":"Journal of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB17|cit17","first-page":"11","article-title":"Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the dose on the efficacy of the long term treatment","volume":"55","author":"Leclere","year":"1994","journal-title":"Annales d'Endocrinologie"},{"issue":"8","key":"10.1002\/14651858.CD003420.pub3-BIB18|cit18","first-page":"2410","article-title":"Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?","volume":"82","author":"Lucas","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD003420.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/BF03348195","article-title":"T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy","volume":"26","author":"Mastorakos","year":"2003","journal-title":"Journal of Endocrinological Investigation"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2265.1999.00629.x","volume":"50","author":"Maugendre","year":"1999","journal-title":"Clinical Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD003420.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJM199601253340403","volume":"334","author":"McIver","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1470583","volume":"147","author":"Nedrebo","year":"2002","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1530\/eje.0.1360081","volume":"136","author":"Pfeilschifter","year":"1997","journal-title":"European Journal of Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD003420.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1420117","volume":"142","author":"Raber","year":"2000","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB25|cit25","first-page":"814","article-title":"Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease","volume":"83","author":"Rittmaster","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7Suppl","key":"10.1002\/14651858.CD003420.pub3-BIB26|cit26","first-page":"A71","volume":"23","author":"Tuncel","year":"2000","journal-title":"Journal of Endocrinological Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003420.pub3-BIB27|cit27","first-page":"337","article-title":"Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse","volume":"87","author":"Weetman","year":"1994","journal-title":"Quarterly Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/qjmed\/89.5.381","volume":"89","author":"Wilson","year":"1996","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD003420.pub3-BIB29|cit29","first-page":"1124","article-title":"Improvement of the prognosis of Basedow's disease by using high doses of carbimazole","volume":"17","author":"Duprey","year":"1988","journal-title":"Presse Medicale"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1996.6.29","volume":"6","author":"Escobar-Morreale","year":"1996","journal-title":"Thyroid"},{"issue":"23","key":"10.1002\/14651858.CD003420.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.239.23.2457","volume":"239","author":"Gwinup","year":"1978","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003420.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF03348036","volume":"21","author":"Hagag","year":"1998","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD003420.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2265.2001.01239.x","volume":"54","author":"Homsanit","year":"2001","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2796.1996.489827000.x","volume":"239","author":"Kallner","year":"1996","journal-title":"Journal of Internal Medicine"},{"issue":"7960","key":"10.1002\/14651858.CD003420.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(76)90414-1","volume":"1","author":"Kristensen","year":"1976","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD003420.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/acta.0.1190139","volume":"119","author":"Mashio","year":"1988","journal-title":"Acta Endocrinologica"},{"issue":"2-3","key":"10.1002\/14651858.CD003420.pub3-BIB37|cit37","first-page":"257","article-title":"Effect of therapy duration and low and highly dosed thiamazole treatment in Basedow's-Graves' disease","volume":"97","author":"Meng","year":"1991","journal-title":"Experimental Clinical Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF03348132","volume":"10","author":"Messina","year":"1987","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD003420.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2265.1988.tb01226.x","volume":"29","author":"O'Malley","year":"1988","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2265.1996.00800.x","volume":"45","author":"Page","year":"1996","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1998.00466.x","volume":"48","author":"Pujol","year":"1998","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD003420.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-57-3-563","article-title":"Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism","volume":"57","author":"Romaldini","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB43|cit43","first-page":"1481","volume":"80","author":"Tamai","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD003420.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.2005.02249.x","article-title":"The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism","volume":"62","author":"Tsai","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD003420.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cccn.2003.10.028","article-title":"Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium","volume":"341","author":"Vrca","year":"2004","journal-title":"Clinica Chimica Acta"},{"issue":"229","key":"10.1002\/14651858.CD003420.pub3-BIB46|cit46","first-page":"409","volume":"59","author":"Weetman","year":"1986","journal-title":"Quarterly Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003420.pub3-BIB47|cit47","first-page":"868","article-title":"The value of early immunosuppressive therapy in the prevention of Graves' disease complications","volume":"61","author":"Huszno","year":"2004","journal-title":"Przeglad Lekarski"},{"issue":"4","key":"10.1002\/14651858.CD003420.pub3-BIB48|cit48","article-title":"Nutritional supplementation for hip fracture aftercare in the elderly. (Cochrane Review)","author":"Avenell","year":"2000","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD003420.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03348703","article-title":"The evolution of Graves' ophthalmopathy during treatment with antithyroid drug alone and combined with triiodothyronine","volume":"15","author":"Bromberg","year":"1992","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD003420.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"key":"10.1002\/14651858.CD003420.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Systematic reviews: Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"British Medical Journal"},{"issue":"24","key":"10.1002\/14651858.CD003420.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM199406163302407","article-title":"The management of hyperthyroidism","volume":"330","author":"Franklyn","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003420.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2265.1998.00558.x","article-title":"Controversies in the management of Graves' disease","volume":"49","author":"Leech","year":"1998","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD003420.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0950-351X(97)80753-7","volume":"11","author":"Toft","year":"1997","journal-title":"Bailliere's Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB55|cit55","first-page":"11","article-title":"Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the dose on the efficacy of the long term treatment","volume":"55","author":"Leclere","year":"1994","journal-title":"Annales d'Endocrinologie"},{"issue":"1","key":"10.1002\/14651858.CD003420.pub3-BIB56|cit56","first-page":"11","article-title":"Treatment of Basedow disease with synthetic antithyroid drugs. Evaluation of the dose on the efficacy of the long term treatment","volume":"55","author":"Leclere","year":"1994","journal-title":"Annales d'Endocrinologie"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003420.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003420.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:20:12Z","timestamp":1628529612000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003420.pub3"}},"subtitle":[],"editor":[{"given":"Prakash","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003420.pub3","relation":{},"subject":[],"published":{"date-parts":[[2005,4,20]]}}}